HANA BIOSCIENCES INC
Profile
Company Names
HANA BIOSCIENCES INC
Addresses
7000 SHORELINE COURT, SUITE 370, SOUTH SAN FRANCISCO, CA 94080
Phone Numbers
650-588-6404
Entity Type:
CORPORATION
Industry:
BIOTECHNOLOGY
Year Incorporated:
> 5 years ago
State Incorporated:
DELAWARE
Total Amount Raised:
$53,779,844.00
Number of Funding Rounds:
2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2010-06-07
$37,512,000.00
$97,562,000.00
$60,050,000.00
Equity
1
2009-10-07
$16,267,844.00
$16,267,844.00
$0.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
NISHAN
DE SILVA
DIRECTOR
STEVEN
R.
DEITCHER, M.D.
EXECUTIVE OFFICER, DIRECTOR
ANDREW
FERRER
DIRECTOR
JONATHAN
LEFF
DIRECTOR
HANA BIOSCIENCES INC
| RIB X PHARMACEUTICALS INC
| TALON THERAPEUTICS, INC.
| N30 PHARMACEUTICALS, INC.
| AUDENTES THERAPEUTICS, INC.
| AVEXIS, INC.
| APRECIA PHARMACEUTICALS CO
| PROTEON THERAPEUTICS INC
| DRACEN PHARMACEUTICALS, INC.
| ARS PHARMACEUTICALS, INC.
| MIRUM PHARMACEUTICALS, INC.
| CHONDRIAL THERAPEUTICS HOLDINGS, LLC
| LARIMAR THERAPEUTICS, INC.
| AVALYN PHARMA INC.
| AEROVATE THERAPEUTICS, INC.
| ADAPTIVE PHAGE THERAPEUTICS, INC.
| INNERVACE, INC.
| BIOMX INC.
| ELION THERAPEUTICS, INC.
| AXONIS THERAPEUTICS, INC.
PAUL
V.
MAIER
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2010-06-07
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2009-10-07
